AIM ImmunoTech Inc. (AIM)
AIM ImmunoTech Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
AIM ImmunoTech Inc. (AIM) is a Biotechnology company based in US with a market capitalization of $847.5K. Revenue declined 48.2% year-over-year and free cash flow was negative at -$11M. This page tracks AIM's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 21 employees · IPO Nov 2, 1995
Valuation
Valuation & price
$0.25as of May 15, 2026· -96.8% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
—
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$847.5K
Market cap
-48.2%
Revenue growth (YoY)
-284.1%
Gross margin
-$11M
Free cash flow (USD)
$3.9M
Net debt
4.8%
Share dilution
0/4
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: May 15, 2026 (EPS $-0.69)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 8-K eventJul 16, 2026Filing
Special Meeting Results
- 8-K eventJun 15, 2026Filing
NYSE Compliance Regained
- 8-K eventJun 11, 2026Filing
Securities Purchase Agreement
- 8-K eventJun 10, 2026Filing
Bylaw Amendment
- 8-K eventJun 4, 2026Filing
Research Presentation Released
- 8-K eventMay 21, 2026Filing
Securities Purchase Agreement
- 8-K eventMay 19, 2026Filing
Debt Refinancing
- Quarterly reportMay 15, 2026Filing
10-Q Filed
- 8-K eventMay 14, 2026Filing
Investor Presentation
- 8-K eventMay 12, 2026Filing
Warrant Issuance
Questions
Frequently asked questions
What is AIM ImmunoTech Inc.'s market cap?
AIM ImmunoTech Inc. (AIM) has a market capitalization of $847.5K.
What is AIM's P/E ratio?
A meaningful P/E ratio is not available for AIM — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
When did AIM ImmunoTech Inc. last report earnings?
AIM last reported earnings on May 15, 2026; the next date is not yet scheduled.
Are insiders buying AIM stock?
SEC Form 4 filings show no open-market insider buys at AIM ImmunoTech Inc. in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.